In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats

[1]  A. Frigessi,et al.  Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. , 2008, Journal of molecular and cellular cardiology.

[2]  A. Veves,et al.  Cannabidiol Attenuates Cardiac Dysfunction , Oxidative Stress , Fibrosis , and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy , 2017 .

[3]  P. Harding,et al.  Fractalkine neutralization improves cardiac function after myocardial infarction , 2015, Experimental physiology.

[4]  Soonkyu Chung,et al.  but not iso-Urolithin A and Urolithin B , attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes 1 , 2017 .

[5]  Yong-liang Wang,et al.  Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy , 2014, Cardiovascular Diabetology.

[6]  C. Edwards,et al.  Colonic Catabolism of Ellagitannins, Ellagic Acid, and Raspberry Anthocyanins: In Vivo and In Vitro Studies , 2011, Drug Metabolism and Disposition.

[7]  P. Harding,et al.  Fractalkine Depresses Cardiomyocyte Contractility , 2013, PloS one.

[8]  R. Ritchie,et al.  Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. , 2014, Pharmacology & therapeutics.

[9]  M. Garcia-Conesa,et al.  Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. , 2012, Molecular nutrition & food research.

[10]  J. Egido,et al.  Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy , 2011, Mediators of inflammation.

[11]  Sung-jin Kim.  Herbal Chrysanthemi Flos, Oxidative Damage and Protection against Diabetic Complications , 2014 .

[12]  D. Del Rio,et al.  Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol , 2016, Nutrients.

[13]  S. Ishikawa,et al.  Role of ER Stress in Ventricular Contractile Dysfunction in Type 2 Diabetes , 2012, PloS one.

[14]  Haobo Li,et al.  Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy , 2016, Cardiovascular Diabetology.

[15]  E. Abel,et al.  Molecular mechanisms of diabetic cardiomyopathy , 2014, Diabetologia.

[16]  Yun Zhang,et al.  Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy. , 2014, International journal of cardiology.

[17]  W. Wang,et al.  Heme Oxygenase-1 Prevents Cardiac Dysfunction in Streptozotocin-Diabetic Mice by Reducing Inflammation, Oxidative Stress, Apoptosis and Enhancing Autophagy , 2013, PloS one.

[18]  B. Cerdá,et al.  Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. , 2007, Journal of agricultural and food chemistry.

[19]  D. Terentyev,et al.  Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart. , 2016, Journal of molecular and cellular cardiology.

[20]  R. Cole,et al.  Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle , 2015, Diabetes.

[21]  M. Periasamy,et al.  Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. , 2010, American journal of physiology. Heart and circulatory physiology.

[22]  Jennifer E Van Eyk,et al.  Multiple Reaction Monitoring to Identify Site-Specific Troponin I Phosphorylated Residues in the Failing Human Heart , 2012, Circulation.

[23]  L. Kang,et al.  Regulation of phospholamban and sarcoplasmic reticulum ca2+-atpase by atorvastatin: implication for cardiac hypertrophy , 2007, Archives of pharmacal research.

[24]  I. Poornima,et al.  Diabetic cardiomyopathy: the search for a unifying hypothesis. , 2006, Circulation research.

[25]  G. García-Rivas,et al.  Regulation of SERCA pumps expression in diabetes. , 2014, Cell calcium.

[26]  R A Bassani,et al.  Relaxation in rabbit and rat cardiac cells: species‐dependent differences in cellular mechanisms. , 1994, The Journal of physiology.

[27]  Kyong Soo Park,et al.  The Use of Ginkgo biloba Extract in Cardiovascular Protection in Patients with Diabetes , 2014 .

[28]  D. Greaves,et al.  Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[29]  S. Granica,et al.  Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages. , 2015, Molecular nutrition & food research.

[30]  Mar Larrosa,et al.  Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far , 2013, Evidence-based complementary and alternative medicine : eCAM.

[31]  M. Garcia-Conesa,et al.  Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1. , 2009, Journal of agricultural and food chemistry.

[32]  Evan G. Williams,et al.  Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents , 2016, Nature Medicine.

[33]  Liya Li,et al.  Chemical characterization and anti-hyperglycaemic effects of polyphenol enriched longan ( Dimocarpus longan Lour.) pericarp extracts , 2015 .

[34]  Hang Ma,et al.  Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species. , 2014, Food & function.

[35]  Soonkyu Chung,et al.  Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes. , 2016, Molecular nutrition & food research.

[36]  J. Espín,et al.  Urolithins are the main urinary microbial-derived phenolic metabolites discriminating a moderate consumption of nuts in free-living subjects with diagnosed metabolic syndrome. , 2012, Journal of agricultural and food chemistry.

[37]  J. Espín,et al.  Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. , 2014, Food & function.

[38]  Chunhong Yan,et al.  Urolithin A attenuates ox-LDL-induced endothelial dysfunction partly by modulating microRNA-27 and ERK/PPAR-γ pathway. , 2016, Molecular nutrition & food research.

[39]  T. Szkudelski,et al.  Resveratrol and diabetes: from animal to human studies. , 2015, Biochimica et biophysica acta.

[40]  F. Mattivi,et al.  Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination? , 2015, ACS chemical neuroscience.

[41]  F. Bernini,et al.  Antiatherogenic effects of ellagic acid and urolithins in vitro. , 2016, Archives of biochemistry and biophysics.

[42]  D. Del Rio,et al.  Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism. , 2015, Food & function.

[43]  R. Sultana,et al.  Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. , 2015, The Journal of nutritional biochemistry.

[44]  R. Schwinger,et al.  Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. , 2003, Cardiovascular research.

[45]  B. Burton-Freeman,et al.  Red Raspberries and Their Bioactive Polyphenols: Cardiometabolic and Neuronal Health Links. , 2016, Advances in nutrition.

[46]  M. Lean,et al.  New insights into the bioavailability of red raspberry anthocyanins and ellagitannins. , 2015, Free radical biology & medicine.

[47]  A. Crozier,et al.  Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions , 2015 .

[48]  N. Seeram,et al.  Pomegranate (Punica granatum) fruit polyphenols, punicalagin, ellagic acid and gallic acid, inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species (975.10) , 2014 .

[49]  M. Garcia-Conesa,et al.  Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. , 2017, Molecular nutrition & food research.

[50]  C. Ulrich,et al.  Pilot walnut intervention study of urolithin bioavailability in human volunteers. , 2014, Journal of agricultural and food chemistry.

[51]  G. Dorn,et al.  Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. , 1996, The Journal of clinical investigation.

[52]  L. Calani,et al.  Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[53]  F. Brighenti,et al.  Effects on Nitric Oxide Production of Urolithins, Gut-Derived Ellagitannin Metabolites, in Human Aortic Endothelial Cells , 2016, Molecules.

[54]  J. Espín,et al.  Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. , 2014, Molecular nutrition & food research.